PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction.

Mouse / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 33017574 ↗2020Reported benefit

Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction.

MouseIschaemia-reperfusionCardiacC57BL/6 wild type; Mx1-Cre inducible Plpp3 (LPP3) knockout with Cre-negative littermate controlsFemalen = 10 to 12 mice per group at 30 days for histology and echoca…Intraperitoneal10 mg/kg per doseStarted immediately after myocardial infarction surgery

Model: Permanent left anterior descending coronary artery ligation under isoflurane to induce acute myocardial infarction; shams had the suture passed without tying. Parallel human cohort of 40 STEMI patients and 5 matched controls.

PF-8380 significantly reduced plasma LPA and autotaxin activity and cut cardiac infiltration of neutrophils, Ly6C-high monocytes and activated macrophages, with lower cardiac and splenic IL-1beta, MCP-1 and TNF-alpha and reduced bone marrow progenitor numbers and proliferation. At 30 days treated m…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.92. Machine-extracted fields require source verification.